clinical efficacy and mechanism of Bifidobacterium lactis M8 in patients with facial acne

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017745

Enrollment

Unknown

Registered

2018-08-12

Start date

2018-08-01

Completion date

Unknown

Last updated

2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

facial acne

Interventions

test group:bifidobacterium lactis m8

control group:placebo

Eligibility

Sex/Gender

All

Age

18 Years to 25 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria for acne; Gender unlimited; Aged 18~25 years old; Able to complete the questionnaire survey; Voluntarily participate in this study and sign informed consent, during treatment, no food and beverage with spicy, thick flavor and probiotics is allowed.

Exclusion criteria

Exclusion criteria: Oral antibiotics, glucocorticoids, immunosuppressants and other drugs in the past 1 month, Using external drugs for the face; Pregnant and lactating women; Complicated with gastrointestinal diseases or gastrointestinal history of surgery, hypertension, diabetes, heart, liver, kidney dysfunction and other systemic diseases.

Design outcomes

Primary

Measure	Time frame
skin lesion type;number of lesions;number of intestinal flora;blood lipid;blood lipid;testosterone;	—

Countries

China

Contacts

Public ContactYu Xuehong

Weihai Municipal Hospital

18660377339@163.com+86 18660377339

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026